Alzheimer’s Disease Clinical Trial Decision-Making Among Patients with Mild Cognitive Impairment and Their Study Partners
<b>Conclusions</b>. Some patients with MCI demonstrated a lack of capacity to consent, impaired health numeracy, or both, putting them at risk for misunderstanding trial information in the consent process for a prodromal AD clinical trial.
Authors
- Steven Tam
- Christian R. Salazar (ORCID: https://orcid.org/0000-0003-3755-275X)
- Megan Witbracht (ORCID: https://orcid.org/0009-0003-0307-3184)
- Adam Birnbaum
- Joshua D. Grill (ORCID: https://orcid.org/0000-0002-4215-7589)
- S. Ahmad Sajjadi (ORCID: https://orcid.org/0000-0002-8960-2213)
- Chelsea G. Cox (ORCID: https://orcid.org/0000-0002-5247-9119)
- Daniel L. Gillen (ORCID: https://orcid.org/0000-0003-1983-9730)
- Gaby Thai
Institutions
- University of California, Irvine (US)
- University of Michigan (US)
- Michigan Institute for Neurological Disorders (US)
- University of Global Health Equity (RW)
Publication Details
- Journal
- AJOB Empirical Bioethics
- Published
- 2025-10-02
- DOI
- https://doi.org/10.1080/23294515.2025.2576830
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00